Objective To investigate the effect of exogenous short-chain fatty acids (SCFAs) on fat metabolism in high-fat-diet induced obese mice. Methods Totally 40 male C57BL/6J mice aged three to four weeks were divided into four groups, and were fed with the normal-fat diet,high-fat diet,high-fat diet with propionate or butyrate for 4 months, respectively.At the end of the experiments, the blood, epididymal and subscapular fat and the liver were collected.Plasma triglyceride (TG) and total cholesterol (TCH) were measured, and hepatic and adipose tissue morphology were examined.Meanwhile, the mRNA expressions of fat metabolism associated genes were assayed by RT-PCR, including the adipose triglyceride lipase (atgl), hormone-sensitive lipase (hsl), acyl CoA:diacylgycerol acyltransferase 2 (dgat2), carnitine palmitoyltransferase (cpt) and uncoupling protein-1 (ucp1). Results Compared with the normal diet group, the body weight, plasma concentrations of TG and TCH, and fat accumulation in the liver significantly increased in the high-fat diet group (P<0.05). Supplementation of propionate or butyrate to the high-fat diet inhibited the increase in body weight and lipid droplet accumulation in the liver, and reduced plasma TG and TCH levels (P<0.05).The RT-PCR analysis showed that the mRNA expressions of atgl, hsl, and cpt1c in both the epididymal fat and liver in high-fat diet group significantly decreased compared with the normal diet group, while the dgat2 expression significantly increased (P<0.05). Supplementation of propionate or butyrate to the high-fat diet increased the mRNA expressions of atgl, hsl, and cpt1c, and reduced the dgat2 expression in the epididymal fat and liver (P<0.05).However, the expression of these genes in the subscapular fat was not affected by dietary propionate or butyrate supplementation (P>0.05). Conclusion Dietary supplementation of propionate and butyrate might inhibit the body weight gain in high-fat-diet induced obese mice by promoting TG lipolysis and oxidation.
Key words
propionate /
butyrate /
obesity /
mouse /
fat metabolism
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Mertz L.Taking on the obesity epidemic :researchers wage a big fat fight in efforts to combat this global health issue [J].IEEE Pulse,2017,8(4):15-19.
[2] Byrne CS, Chambers ES, Morrison DJ,et al.Morrison and G Frost.The role of short chain fatty acids in appetite regulation and energy homeostasis[J].Int J Obes (Lond),2015,39(9):1331-1338.
[3] Tan J, McKenzie C, Potamitis M, et al.The role of short-chain fatty acids in health and disease[J].Adv Immunol,2014,121:91-119.
[4] Yan H, Ajuwon KM.Mechanism of butyrate stimulation of triglyceride storage and adipokine expression during adipogenic differentiation of porcine stromovascular cells[J].PLoS One,2015,10(12):e0145940.
[5] Baothman OA, Zamzami MA, Taher I, et al.The role of gut microbiota in the development of obesity and diabetes [J].Lipids Health Dis,2016,15:108.
[6] Moreno-Indias I, Cardona F, Tinahones FJ, et al.Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus [J].Front Microbiol,2014,5:190.
[7] Khan MJ, Gerasimidis K, Edwards CA, et al.Role of gut microbiota in the aetiology of obesity:proposed mechanisms and review of the literature [J].J Obes,2016:7353642.
[8] Kasubuchi M, Hasegawa S, Hiramatsu T, et al.Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation[J].Nutrients,2015,7(4):2839-2849.
[9] Venema K.Microbial metabolites produced by the colonic microbiota from prebiotics as drivers for immunomodulation in the host[J].Pharma Nutrition,2014,2(3):118.
[10] Canfora EE, Jocken JW, Blaak EE.Short-chain fatty acids in control of body weight and insulin sensitivity[J].Nat Rev Endocrinol,2015,11(10):577-591.
[11] Lu Y, Fan C, Li P, et al.Short chain fatty acids prevent high-fat-diet-induced obesity in mice by regulating g protein-coupled receptors and gut microbiota[J].Sci Rep,2016,6:37589.
[12] Bauer PV, Hamr SC, Duca FA.Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota [J].Cell Mol Life Sci,2016,73(4):737-755.
[13] Cani PD, Delzenne NM.The gut microbiome as therapeutic target[J].Pharmacol Ther,2011,130(2):202-212.
[14] Raybould HE.Gut microbiota, epithelial function and derangements in obesity[J].J Physiol,2012,590(3):441-446.
[15] Bolsoni-Lopes A, Alonso-Vale MI.Lipolysis and lipases in white adipose tissue-an update[J].Arch Endocrinol Metab,2015,59(4):335-342.
[16] den Besten G, van Eunen K, Groen AK, et al.The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism[J].J Lipid Res,2013,54(9):2325-2340.
[17] Qu Q, Zeng F, Liu X, et al.Fatty acid oxidation and carnitine palmitoyltransferase I:emerging therapeutic targets in cancer[J].Cell Death Dis,2016,7:e2226.
[18] Lukovac S, Belzer C, Pellis L, et al.Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids[J].MBio,2014,5(4):pii:e01438-14.
[19] Heimann E, Nyman M, Degerman E.Propionic acid and butyric acid inhibit lipolysis and de novo lipogenesis and increase insulin-stimulated glucose uptake in primary rat adipocytes[J].Adipocyte,2014,4(2):81-88.
PDF(957 KB)
